With a fixed-effect model, non-female cancer patients with high H19 expression had a shorter DFS than those with low H19 expression (Figure 6; pooling HR = 1.43, 95 % CI = 1.23 - 1.66, p < 0.0001). Here, H19 is linked to cancer.